| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the The Burnham Institute,*
La Jolla, California;
the University Department of Paediatric
Gastroenterology,
Royal Free and University
College School of Medicine, London, United Kingdom; the Institute of
Child Health,
University College, London,
United Kingdom; and St. Marks Hospital,§
Harrow, United Kingdom
Intestinal biopsy in a boy with gastroenteritis-induced
protein-losing enteropathy (PLE) showed loss of heparan sulfate (HS)
and syndecan-1 core protein from the basolateral surface of the
enterocytes, which improved after PLE subsided. Isoelectric
focusing analysis of serum transferrin indicated a congenital disorder
of glycosylation (CDG) and subsequent analysis showed three point
mutations in the ALG6 gene encoding an
1,3-glucosyltransferase needed for the addition of the first
glucose to the dolichol-linked oligosaccharide. The maternal
mutation, C998T, causing an A333V substitution,
has been shown to cause CDG-Ic, whereas the two paternal
mutations, T391C (Y131H) and C924A (S308R) have not previously
been reported. The mutations were tested for their ability to rescue
faulty N-linked glycosylation of carboxypeptidase Y in
an ALG6-deficient Saccharomyces
cerevisiae strain. Normal human ALG6 rescues
glycosylation and A333V partially rescues, whereas the combined
paternal mutations (Y131H and S308R) are ineffective.
Underglycosylation resulting from each of these mutations is much more
severe in rapidly dividing yeast. Similarly, incomplete protein
glycosylation in the patient is most severe in rapidly dividing
enterocytes during gastroenteritis-induced stress. Incomplete
N-linked glycosylation of an HS core protein and/or
other biosynthetic enzymes may explain the selective localized loss of
HS and PLE.
This article has been cited by other articles:
![]() |
B. Amadi, A. O Fagbemi, P. Kelly, M. Mwiya, F. Torrente, C. Salvestrini, R. Day, M. H Golden, E. A Eklund, H. H Freeze, et al. Reduced production of sulfated glycosaminoglycans occurs in Zambian children with kwashiorkor but not marasmus Am. J. Clinical Nutrition, February 1, 2009; 89(2): 592 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ostrow, H. Freeze, and J. Rychik Protein-Losing Enteropathy After Fontan Operation: Investigations Into Possible Pathophysiologic Mechanisms Ann. Thorac. Surg., August 1, 2006; 82(2): 695 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bode, S. Murch, and H. H. Freeze Heparan Sulfate Plays a Central Role in a Dynamic in Vitro Model of Protein-losing Enteropathy J. Biol. Chem., March 24, 2006; 281(12): 7809 - 7815. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bode, E. A. Eklund, S. Murch, and H. H. Freeze Heparan sulfate depletion amplifies TNF-{alpha}-induced protein leakage in an in vitro model of protein-losing enteropathy Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1015 - G1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Westphal, S. Kjaergaard, E. Schollen, K. Martens, S. Grunewald, M. Schwartz, G. Matthijs, and H. H. Freeze A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency Hum. Mol. Genet., March 1, 2002; 11(5): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Freeze Update and perspectives on congenital disorders of glycosylation Glycobiology, December 1, 2001; 11(12): 129R - 143R. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |